Please assess the completion status of the following clinical trial:

Trial Title: Suboptimal Weight Loss After Gastric Bypass Surgery

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Body mass index (BMI) \>40kg/m2, or BMI\>35kg/m2 with comorbidities~* healthy volunteers with suboptimal weight loss~* health with significant weight regain after Roux-n-Y Gastric Bypass, defined as failure to lose at least 40% Excess Weight Loss by 12 months postoperatively.~Significant weight regain: Regain of ≥15% of total weight lost after the first postoperative year.~Exclusion Criteria:~* Pregnancy~* enrollment in another obesity treatment~* previous revisional bariatric surgery~* planned bariatric surgery~* past or ongoing drug or alcohol abuse~* physical or mental impairment that interferes with the ability to comply to treatment~* history of severe psychological disorder~* history of severe eating disorder~* current medication known to affect appetite or induce weight loss

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Outpatient group (Type: EXPERIMENTAL): Multidisciplinary outpatient programme including both individual and group-based therapy. During the first visit, every patient will have an individual consultation with the dietician, physiotherapist and psychiatric nurse. After this, the patients will be followed up in groups every month for the first four months and every two months afterwards up to one year. The intervention will focus on nutritional education, healthy eating, increased physical activity levels (aiming initially at 10 minutes/day, then increasing to 30 minutes/day) and cognitive therapy.
- Inpatient group (Type: EXPERIMENTAL): Inpatient lifestyle programme offered at a rehabilitation center consisting of a continuous care weight loss program, with three intermittent stays (each with three-week duration) over a one year period.

Based on this trial design, predict the completion outcome and termination type (if applicable).